Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages.

Abstract:

:In this study 10(7) peripheral blood mononuclear cells including on average 78.56% CD19+/CD5+ lymphocytes were irradiated, and then administered intradermally as an anti-cancer vaccine to seventeen patients with B-cell chronic lymphocytic leukemia (B-CLL) at early stages (twelve injections, four at a weekly interval followed by eight vaccines given every two weeks). In eight out of seventeen patients, in the first two injections, irradiated leukemic cells were mixed with bacillus Calmette-Guerin (BCG) to improve the efficacy of therapy by additional induction of innate immunity. A hematological improvement (as defined by a >25% reduction of leukocyte count) to autologous leukemic cell vaccines was observed in 5/17 patients, stabilisation of disease in 5/17 patients and in 7/17 patients there was no response to immunotherapy. In seven patients significant increase of the lymphocyte doubling time was noted (p=0.02). There was no impact of BCG for immune responses or clinical outcome of vaccinated patients, but there was a significant increase of the absolute counts of CD3+ as well as of CD3+/CD4+ and CD3+/CD8+ T cells during the vaccination period. We observed a significant improvement of the phagocytic function of autologous dendritic cells generated from peripheral blood monocytes obtained from patients with B-CLL after the end of immunotherapy (p=0.006). An association between the clinical outcome and the percentage of leukemic cells positive for expression of ZAP-70 and CD38 was noted. In conclusion, our results demonstrated the feasibility and safety of autologous irradiated leukemic cell immunotherapy in patients with B-CLL. As we noted immunological, and to some extent, clinical responses, this approach merits further investigation, including the use of adjuvants other than BCG.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Hus I,Kawiak J,Tabarkiewicz J,Radej S,Hoser G,Bojarska-Junak A,Schmitt M,Giannopoulos K,Dmoszynska A,Rolinski J

subject

Has Abstract

pub_date

2008-08-01 00:00:00

pages

443-51

issue

2

eissn

1021-335X

issn

1791-2431

journal_volume

20

pub_type

杂志文章
  • Transcriptional repression of vimentin gene expression by pyrroline dithiocarbamate during 12-O-tetradecanoylphorbol-13-acetate-dependent differentiation of HL-60 cells.

    abstract::Vimentin is a member of the intermediate filament family, and the NF-kappaB binding site is located in the human vimentin promoter. To gain insight into the role of NF-kappaB in the regulation of the vimentin gene during 12-O-tetradecanoylphorbol-13-acetate (TPA)-dependent differentiation of HL-60 cells, the effect of...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zheng M,Son MY,Park C,Park JI,Jo EK,Yoon WH,Park SK,Hwang BD,Lim K

    更新日期:2005-09-01 00:00:00

  • Suppression of DRP1‑mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy.

    abstract::The efficacy of chemotherapy for hepatocellular carcinoma (HCC) remains unsatisfactory, primarily due to inherent self‑defense mechanisms (e.g., mitophagy and autophagy). In the present study, we aimed to explore the pro‑apoptotic effects of targeting mitophagy to potentiate the efficacy of chemotherapy for HCC. HCC c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7476

    authors: Ma M,Lin XH,Liu HH,Zhang R,Chen RX

    更新日期:2020-03-01 00:00:00

  • A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.

    abstract::Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) treatment is effective for the treatment of primary tumors, but not sufficient for the treatment of metastatic tumors, likely owing to the effects of the tumor microenvironment. In this study, we aimed to determine the therapeutic effects of combined treatment with a matr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4547

    authors: Li M,Xing S,Zhang H,Shang S,Li X,Ren B,Li G,Chang X,Li Y,Li W

    更新日期:2016-03-01 00:00:00

  • Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.

    abstract::To estimate the incidence of Epstein-Barr virus-associated gastric carcinoma (EBV-GC) in Colombia and to clarify its clinicopathological features, we examined 178 consecutive gastric carcinoma cases, diagnosed during the period from 1996 to 1998, at Hospital Universitario del Valle in Cali, Colombia. The mean age of t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Carrascal E,Koriyama C,Akiba S,Tamayo O,Itoh T,Eizuru Y,Garcia F,Sera M,Carrasquilla G,Piazuelo MB,Florez L,Bravo JC

    更新日期:2003-07-01 00:00:00

  • Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.

    abstract::The characteristics of ovarian cancers that showed low activation of glycolysis were investigated. Using medical records of patients with ovarian cancers who had undergone fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) prior to their primary surgery at the University of Tokyo Hospital...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5398

    authors: Sato M,Kawana K,Adachi K,Fujimoto A,Taguchi A,Fujikawa T,Yoshida M,Nakamura H,Nishida H,Inoue T,Ogishima J,Eguchi S,Yamashita A,Tomio K,Arimoto T,Wada-Hiraike O,Oda K,Nagamatsu T,Osuga Y,Fujii T

    更新日期:2017-03-01 00:00:00

  • Induction of cell growth arrest and apoptotic cell death in human breast cancer MCF-7 cells by the COX-1 inhibitor FR122047.

    abstract::Non-steroidal anti-inflammatory drugs (NSAIDs), which inhibit the enzyme cyclooxygenase (COX), are known to have a potent anti-tumorigenic activity in various cancers. However, the responsible molecular mechanisms of COX inhibition in breast cancer cells remain to be completely elucidated. We examined the effect of th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000866

    authors: Jeong HS,Kim JH,Choi HY,Lee ER,Cho SG

    更新日期:2010-08-01 00:00:00

  • miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.

    abstract::microRNAs (miRNAs) are known to be involved in the pathogenesis of hepatocellular carcinoma (HCC). miR-128-3p was recently reported to be deregulated in several types of cancer. However, the biological function and potential mechanisms of miR-128-3p in HCC remain unknown. In the present study, we found that miR-128-3p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3936

    authors: Huang CY,Huang XP,Zhu JY,Chen ZG,Li XJ,Zhang XH,Huang S,He JB,Lian F,Zhao YN,Wu GB

    更新日期:2015-06-01 00:00:00

  • A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.

    abstract::The majority of patients with hormone receptor-positive metastatic breast cancer die from disease progression despite different types of anti-hormonal treatments. Preclinical studies have indicated that resistance to anti-hormonal therapies may be the result of an activated NF-κB si...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1562

    authors: Trinh XB,Sas L,Van Laere SJ,Prové A,Deleu I,Rasschaert M,Van de Velde H,Vinken P,Vermeulen PB,Van Dam PA,Wojtasik A,De Mesmaeker P,Tjalma WA,Dirix LY

    更新日期:2012-03-01 00:00:00

  • High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.

    abstract::The TP53 mutation (R175H) is one of the most common mutations in human cancer. It is a highly attractive strategy for cancer therapy to find the genes that lead the R175H-expressing cancer cells. The aim of this study was to identify the synthetic sick/lethal gene interacting with R175H. Using lentiviral bar-coded com...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2953

    authors: Imai H,Kato S,Sakamoto Y,Kakudo Y,Shimodaira H,Ishioka C

    更新日期:2014-03-01 00:00:00

  • Aberrant expression of class III beta-tubulin in basal cell carcinoma of the skin.

    abstract::Tubulin is a major component of microtubules. Class III beta-tubulin (beta III) is a neuron-associated beta-tubulin isotype and expressed in the normal central and peripheral nervous systems. According to a previous study, beta III is not expressed in normal skin and squamous cell carcinoma. However, its expression ha...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000494

    authors: Ishida M,Kushima R,Okabe H

    更新日期:2009-10-01 00:00:00

  • Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).

    abstract::Gastric cancer (GC) is one of the most common causes of cancer‑related mortality worldwide. Despite remarkable progress in the diagnosis and treatment of GC, a large number of cases are diagnosed as advanced GC, and treatment failure occurs. Emerging evidence has shown that non‑coding RNAs (ncRNAs), especially microRN...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7705

    authors: Shao Z,Gao D,Chen L,Ding W,Yu Q

    更新日期:2020-10-01 00:00:00

  • Epigenetic alterations associated with cholangiocarcinoma (review).

    abstract::Cholangiocarcinoma (CCA) is a highly lethal malignant tumor arising from the biliary tract epithelium. Chronic inflammatory conditions, including primary sclerosing cholangitis, liver fluke infestation, and hepatolithiasis, are considered risk factors, but the cause is still unknown in most cases. Recent advances in m...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:

    authors: Isomoto H

    更新日期:2009-08-01 00:00:00

  • Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

    abstract::The advent of pathotropic (disease-seeking) targeting has transported genetic medicine across the threshold of history with the progressive clinical validation of Rexin-G, a tumor-targeted nanosized anti-cancer agent. Achieving noteworthy single-agent efficacy and survival benefits in otherwise intractable cancers, th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.829

    authors: Hall FL,Levy JP,Reed RA,Petchpud WN,Chua VS,Chawla SP,Gordon EM

    更新日期:2010-10-01 00:00:00

  • Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.

    abstract::The usefulness of the in vitro chemosensitivity test, the collagen gel droplet embedded culture drug- sensitivity test (CD-DST, Int J Oncol 11: 449, 1997), in cisplatin-based combined chemotherapy for postoperative recurrent tumors in non-small cell lung cancer (NSCLC) patients was retrospectively analyzed. CD-DST dat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.2.279

    authors: Higashiyama M,Kodama K,Yokouchi H,Takami K,Nakagawa H,Imamura F,Minamigawa K,Kobayashi H

    更新日期:2001-03-01 00:00:00

  • The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.

    abstract::Mammary stem cells (MSCs) are the progenitor population for human breast epithelia. MSCs give rise during mammary gland development to estrogen receptor (ER)-negative basal cells and the ER- luminal progenitor (LP) population which maintains ER+ and ER- luminal cells. The MSC population is expanded and tumorigenic in ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4003

    authors: Wu J,Crowe DL

    更新日期:2015-07-01 00:00:00

  • Curcumin and paclitaxel induce cell death in breast cancer cell lines.

    abstract::Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer that exerts antitumor activity in numerous types of cancer cell. Curcumin (diferuloylmethane), ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6603

    authors: Calaf GM,Ponce-Cusi R,Carrión F

    更新日期:2018-10-01 00:00:00

  • Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections.

    abstract::Lymph node metastases are responsible for shorter survival in oral squamous cell carcinoma (OSCC). The aim of the present study was to assess the node metastasis frequency and survival according to the node metastasis features in 121 neck dissections (NDs) performed for OSCC, identifying evidence-based correlations an...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2779

    authors: Contaldo M,Di Napoli A,Pannone G,Franco R,Ionna F,Feola A,De Rosa A,Santoro A,Sbordone C,Longo F,Pasquali D,Loreto C,Ricciardiello F,Esposito G,D'Angelo L,Itro A,Bufo P,Tombolini V,Serpico R,Di Domenico M

    更新日期:2013-12-01 00:00:00

  • Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.

    abstract::Tanshinone IIA is known to induce apoptosis in several types of cancer cells. However, little is known about its activity in chemoresistant cells. The aim of this study was to investigate the anticancer properties of tanshinone IIA in cisplatin-resistant human ovarian cancer COC1/DDP cells in vitro. We used a variety ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1107

    authors: Jiao JW,Wen F

    更新日期:2011-03-01 00:00:00

  • Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.

    abstract::Drug resistance is one of the major obstacles to chemotherapy of ovarian cancer. Studies with cell lines can serve as an initial screen for agents that might modulate drug resistance. To establish more appropriate models of drug resistance and explore whether the differences exist in the different drug resistant subli...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yan XD,Li M,Yuan Y,Mao N,Pan LY

    更新日期:2007-05-01 00:00:00

  • Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.

    abstract::The estrogen receptor (ER) expression and HER2 amplification are important factors in determining the prognosis and therapy of breast cancer. Interactions between the two signaling pathways for example resulted in ERalpha-dependent regulation of HER2 expression in breast cancer cells. In this study, we investigated to...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Lattrich C,Juhasz-Boess I,Ortmann O,Treeck O

    更新日期:2008-03-01 00:00:00

  • Antitumor effects of nano-bubble hydrogen-dissolved water are enhanced by coexistent platinum colloid and the combined hyperthermia with apoptosis-like cell death.

    abstract::In order to erase reactive oxygen species (ROS) related with the proliferation of tumor cells by reducing activity of hydrogen, we developed functional water containing nano-bubbles (diameters: <900 nm for 71%/population) hydrogen of 1.1-1.5 ppm (the theoretical maximum: 1.6 ppm) with a reducing ability (an oxidation-...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00001006

    authors: Asada R,Kageyama K,Tanaka H,Matsui H,Kimura M,Saitoh Y,Miwa N

    更新日期:2010-12-01 00:00:00

  • Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera.

    abstract::Elevated serum CA15‑3 assessed by enzyme‑linked immunosorbent assay (ELISA) has been considered a diagnostic marker of breast cancer. However, accumulating data indicate that the current ELISA system for detecting CA15‑3, which targets the peptide backbone of CA15‑3, is not sufficiently sensitive to detect early or lo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6433

    authors: Choi JW,Moon BI,Lee JW,Kim HJ,Jin Y,Kim HJ

    更新日期:2018-07-01 00:00:00

  • Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.

    abstract::Given the important role of CXCR4 in cancer metastasis, microenvironmental factors that modulate CXCR4 may have an impact on the process of tumor expansion. Hypoxia is a common feature of solid tumors and a significant microenvironmental factor that drives aggressive behavior. CXCR4...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2063

    authors: Oh YS,Kim HY,Song IC,Yun HJ,Jo DY,Kim S,Lee HJ

    更新日期:2012-12-01 00:00:00

  • Analysis of caspase activities in rat mammary tumours induced by N-methyl-nitrosourea.

    abstract::Normal breast development is controlled by a balance between cell proliferation and apoptosis. The balance between the two parameters is crucial for determining the growth or regression of breast tumours in response to therapies and treatments. Therefore, it is necessary to understand the role of apoptosis in tumour p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Puertollano MA,Carrera MP,Puertollano E,Alvarez de Cienfuegos G,Ramirez-Expósito MJ,De Pablo MA,Martinez-Martos JM

    更新日期:2008-09-01 00:00:00

  • Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.

    abstract::Numerous studies have demonstrated that triptolide induces cell cycle arrest and apoptosis in human cancer cell lines. However, triptolide-induced DNA damage and inhibition of DNA repair gene expression in human skin cancer cells has not previously been reported. We sought the effects of triptolide on DNA damage and a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2170

    authors: Chueh FS,Chen YL,Hsu SC,Yang JS,Hsueh SC,Ji BC,Lu HF,Chung JG

    更新日期:2013-02-01 00:00:00

  • Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.

    abstract::Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are involved in tumor invasion, but their prognostic significance is still under discussion. We set out to analyze the epithelial and stromal expression of MMP-2, MMP-7, MMP-9, MT1-MMP, TIMP-1 and TIMP-2 in advanced epithelial ovarian cancers and to ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1608

    authors: Brun JL,Cortez A,Lesieur B,Uzan S,Rouzier R,Daraï E

    更新日期:2012-04-01 00:00:00

  • Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.

    abstract::The promigratory molecule L1CAM is overexpressed in various tumors, often representing an unfavorable prognostic marker. Recently, we identified L1CAM expression in pancreatic ductal adenocarcinoma (PDAC) cells accounting for chemoresistance and increased cell migration. Thus, the present study aims at further elucida...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.909

    authors: Bergmann F,Wandschneider F,Sipos B,Moldenhauer G,Schniewind B,Welsch T,Schirrmacher P,Klöppel G,Altevogt P,Schäfer H,Sebens Müerköster S

    更新日期:2010-10-01 00:00:00

  • Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

    abstract::In preclinical studies, antagonists of growth hormone-releasing hormone (GHRH) have demonstrated inhibitory effects on the growth of various types of cancers expressing the pituitary type of GHRH receptors (pGHRH-R) and/or its active splice variant 1 (SV1). In this study, we investigated the effectiveness of the treat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2435

    authors: Seitz S,Rick FG,Schally AV,Treszl A,Hohla F,Szalontay L,Zarandi M,Ortmann O,Engel JB,Buchholz S

    更新日期:2013-07-01 00:00:00

  • Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.

    abstract::Genetically modified tumour cells producing cytokines such as interleukin 12 (IL-12) are potent activators of the antitumour immune responses and represent a promising therapeutic modality when combined with chemotherapy. The objective of this study was to examine whether IL-12-producing cellular vaccines can augment ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1221

    authors: Mikyšková R,Indrová M,Símová J,Bieblová J,Bubeník J,Reiniš M

    更新日期:2011-06-01 00:00:00

  • Comparative effects of dimethylbenz(a)anthacene and a 15% olive-oil diet on cellular components and expression of apoptosis-related proteins in the spleen and mammary gland tumors of rats.

    abstract::We compared effects of a high fat diet and a carcinogen on cellular elements of the spleen and mammary gland tumors in rats. Animals were fed a 15% olive-oil diet and a group of them were exposed to a carcinogen, dimethylbenz(a)anthacene (DMBA), in two doses of 10 mg/rat. Results of the experiments were evaluated afte...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.2.435

    authors: Kossoy G,Yarden G,Ben-Hur H,Kossoy N,Stark A,Madar Z,Zusman I

    更新日期:2001-03-01 00:00:00